# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Cleopatra (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC003-SYN
- Date: 2026-06-23
- Fictional facility: St. Posthumous Health Center
- Fictional author: Nefeli Arvanitis-Osei, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Prenatal visit at 25 weeks with the growth scan and glucose challenge. **S**

## History of present illness

Cleopatra returns at 25 weeks 0 days. The gastroenteritis three weeks ago settled within two days with oral fluids, and the tightenings stopped with it; she has had none since. Both babies move often. She takes aspirin, the prenatal vitamin, and ferrous sulfate every other day. She has no headache, visual change, swelling of the face or hands, bleeding, leaking fluid, or urinary symptoms. She is still working full days but has moved most of her meetings to the mornings and rests in the afternoon. She had the growth scan and the glucose challenge this morning. **S**

| Element | Detail |
|---|---|
| Gastroenteritis | Resolved within two days; no tightenings since |
| Fetal movement | Both babies moving often |
| Work | Full days with an afternoon rest |
| Tests today | Growth scan, glucose challenge, blood count |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Well |
| Neurological | Negative | No headache or visual change |
| Genitourinary | Negative | No bleeding, leaking fluid, or urinary symptoms |
| Obstetric | Negative | No tightenings or pelvic pressure |
| Psychiatric | Negative | Mood steady; EPDS 7 |

5 systems reviewed. **S**

## Current medications

- Prenatal vitamin containing folic acid 0.4 mg, one tablet by mouth daily **S**
- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day **S**
- Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtime **S**

## Allergies

- No known allergy **S**

## Objective

BP 108/66 mmHg; pulse 90 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 64.2 kg; BMI 23.6 kg/m². All vital signs are synthetic.

Hemoglobin: 10.9 g/dL; Ferritin: 31 ng/mL; Platelets: 241 10*3/uL; 1-hour glucose challenge: 128 mg/dL; Estimated fetal weight, twin A: 760 g; Estimated fetal weight, twin B: 720 g; EPDS: 7. All results are synthetic.

## Change since baseline

- Hemoglobin: 10.8 g/dL (low) at baseline, 10.9 g/dL at this visit **S**
- Ferritin: 14 ng/mL (low) at baseline, 31 ng/mL at this visit **S**
- Platelets: 268 10*3/uL at baseline, 241 10*3/uL at this visit **S**
- EPDS: 6 at baseline, 7 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Abdomen | Fundal height 29 cm, consistent with twins at 25 weeks; non-tender |
| Fetal | Scan: estimated weights 760 and 720 g, discordance 5 percent; normal fluid; fetal hearts 144 and 140 per minute |
| Extremities | No edema |
| Urine dipstick | Protein negative |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Twin pregnancy, dichorionic diamniotic** (O30.041). Concordant growth (5 percent), normal fluid and Doppler. One-hour glucose challenge 128 mg/dL, below 140: no gestational diabetes. Platelets 241. Blood pressure 108/66 mmHg. EPDS 7 with item 10 scored 0. **S**
   - Continue aspirin.
   - Prenatal visit with the next growth scan at 29 weeks.
   - Tdap at 27 to 36 weeks; visits every two weeks from 28 weeks.
2. **Iron deficiency anemia in pregnancy** (O99.011). Hemoglobin 10.9 g/dL and ferritin 31 ng/mL: iron stores replete. **S**
   - Continue ferrous sulfate every other day through the pregnancy.
   - Blood count in the third trimester.
3. **Acute viral gastroenteritis** (O98.512). Resolved; no preterm labor. **S**
   - No further action.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure and urine protein | Every prenatal visit | Completed today | 108/66 mmHg; urine protein negative |
| Examination | Fetal hearts and fundal height | Every prenatal visit | Completed today | Fetal hearts 144 and 140 per minute; fundal height 29 cm |
| Examination | Weight gain (about 17 to 25 kg for twins from a normal BMI) | Every prenatal visit | Completed today | 64.2 kg, up 6.2 kg since intake |
| Imaging | Growth scan with discordance | Every four weeks from about 20 to 24 weeks in a dichorionic twin pregnancy | Completed today | 760 and 720 g; discordance 5 percent; normal fluid and umbilical artery Doppler |
| Laboratory | Hemoglobin and ferritin | At intake, at the anatomy-scan visit, at 24 to 28 weeks, and in the third trimester | Completed today | Hemoglobin 10.9 g/dL and ferritin 31 ng/mL; platelets 241 |
| Laboratory | Gestational diabetes screen (one-hour 50 g glucose challenge) | At 24 to 28 weeks | Completed today | 128 mg/dL, below the 140 mg/dL threshold |
| Laboratory | Antibody screen and anti-D at 28 weeks | At 28 weeks for RhD-negative patients | Not indicated | RhD positive with a negative antibody screen at intake |
| Survey | Perinatal mood screen (EPDS) | Each trimester | Completed today | 7; item 10 scored 0 |
| Medication safety | Low-dose aspirin | Daily from 12 weeks until delivery; review at every visit | Completed today | Taken nightly; held for one night during the gastroenteritis; no bleeding |
| Medication safety | Tdap vaccine | Once at 27 to 36 weeks in every pregnancy | Due | At the next visit |
| Self-management | Preterm labor warning signs | Every prenatal visit | Completed today | No tightenings since the gastroenteritis; warning signs reviewed |

## Goal progress

- The cause of the large uterus and the dating of the pregnancy established at the 11-week scan. Outcome by 2026-03-17: Dichorionic diamniotic twins; dating by her last period confirmed by the crown-rump lengths. **S**
- An informed choice about aneuploidy screening by 14 weeks. Outcome by 2026-03-17: Chose nuchal translucency for each twin with cell-free DNA; declined diagnostic testing for now. **S**
- Hemoglobin and ferritin in the normal range for pregnancy by the third trimester. In progress; target 2026-08-18. **S**
- Growth discordance under 20 percent at every growth scan. In progress; target 2026-08-18. **S**
- A written delivery plan agreed by 34 weeks. In progress; target 2026-08-18. **S**

## Guideline basis

- Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231 (2021), American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine (Obstetrics & Gynecology)
- Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021), U.S. Preventive Services Task Force
- ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus (2018), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 4 (2023), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)

## Follow-up

- Prenatal visit with the growth scan at 29 weeks, then every two weeks. **S**
- Next scheduled visit 2026-08-18: prenatal visit at 33 weeks: growth scan, Tdap, and the delivery plan. **S**
